Interleukin-6 as surrogate marker for imaging-based hypoxia dynamics in patients with head-and-neck cancers undergoing definitive chemoradiation-results from a prospective pilot trial.

Alexander RühleNicole WiedenmannJamina T FennellMichael MixJuri RufRaluca StoianAndreas R ThomsenPeter VaupelDimos BaltasAnca-L GrosuNils Henrik Nicolay

Published in: European journal of nuclear medicine and molecular imaging (2021)

The prospective trial was registered in the German Clinical Trial Register (DRKS00003830). Registered 20 August 2015.

Keyphrases

clinical trial
phase ii
study protocol
phase iii
locally advanced
high resolution
open label
randomized controlled trial
endothelial cells
squamous cell carcinoma
double blind
radiation therapy
mass spectrometry